Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders. (Q37508942)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

1 reference

ChEBI release 2020-05-28

Lee A Dawson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Jeannette M Watson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

107-117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

The role of serotonin in the pathophysiology and treatment of schizophrenia

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00067.X

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00067.X

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00067.X

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00067.X

Serotonin and hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00067.X

Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00067.X

Evidence for postsynaptic mediation of the hypothermic effect of 5-HT1A receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00067.X

Is the forced swimming test a suitable model for revealing antidepressant activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00067.X

Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00067.X

Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00067.X

Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors

21 January 2018

1 reference

12 December 2020

Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention

1 reference

12 December 2020

New approaches to the treatment of refractory depression.

1 reference

12 December 2020

Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates

1 reference

12 December 2020

Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study

1 reference

12 December 2020

5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems

1 reference

12 December 2020

Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT(1A) receptor antagonist WAY100635.

1 reference

12 December 2020

Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines

1 reference

12 December 2020

Drug action at the 5-HT1A receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-11C]WAY-100635

1 reference

12 December 2020

Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635.

1 reference

12 December 2020

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

1 reference

12 December 2020

Systemic EMD 68843 injections reduce anxiety in the shock-probe, but not the plus-maze test

1 reference

12 December 2020

Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures.

1 reference

12 December 2020

SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue

1 reference

12 December 2020

Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.

1 reference

12 December 2020

In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography.

1 reference

12 December 2020

Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex

1 reference

12 December 2020

Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist

1 reference

12 December 2020

Is there a role for 5-HT1A agonists in the treatment of depression?

1 reference

12 December 2020

Modulation of serotonergic function in rat brain by VN2222, a serotonin reuptake inhibitor and 5-HT1A receptor agonist.

1 reference

12 December 2020

Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes

1 reference

12 December 2020

Current concepts in the pharmacological treatment of obsessive-compulsive disorder

1 reference

12 December 2020

Acceleration of onset of action in schedule-induced polydipsia: combinations of SSRI and 5-HT1A and 5-HT1B receptor antagonists

1 reference

12 December 2020

A new synthesis of indole 5-carboxylic acids and 6-hydroxy-indole-5-carboxylic acids in the preparation of an o-hydroxylated metabolite of vilazodone

1 reference

12 December 2020

Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity

1 reference

12 December 2020

Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors

1 reference

12 December 2020

Effects of systemic injections of vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats

1 reference

12 December 2020

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

1 reference

12 December 2020

Strategies for producing faster acting antidepressants.

1 reference

12 December 2020

Effect of vilazodone on 5-HT efflux and re-uptake in the guinea-pig dorsal raphe nucleus

1 reference

12 December 2020

Pindolol augmentation of antidepressant response

1 reference

12 December 2020

Medication augmentation after the failure of SSRIs for depression.

1 reference

12 December 2020

SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.

1 reference

12 December 2020

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

1 reference

12 December 2020

Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment

1 reference

12 December 2020

Behavioral studies of serotonin receptor agonists as antidepressant drugs

1 reference

12 December 2020

Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies

1 reference

12 December 2020

Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates.

1 reference

12 December 2020

Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis

1 reference

12 December 2020

5-HT1 receptor augmentation strategies as enhanced efficacy: therapeutics for psychiatric disorders

1 reference

12 December 2020

Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.

1 reference

12 December 2020

A comparison of anxiolytic and nonanxiolytic agents in the shock-probe/burying test for anxiolytics

1 reference

12 December 2020

A role for 5-HT in the action of antidepressant drugs.

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain.

1 reference

12 December 2020

Attenuated feed-back inhibition of brain serotonin synthesis following chronic administration of imipramine

1 reference

12 December 2020

Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain.

1 reference

12 December 2020

Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression

1 reference

12 December 2020

Depressions following reserpine: a reevaluation

1 reference

12 December 2020

Tryptophan in the treatment of depression.

1 reference

12 December 2020

Depression: a new animal model sensitive to antidepressant treatments

1 reference

12 December 2020

Tryptamine metabolism in depression

1 reference

12 December 2020

Behavioral despair in mice: a primary screening test for antidepressants

1 reference

12 December 2020

Enhancement of the Antidepressant Response to <i>L</i>-Tryptophan by a Liver Pyrrolase Inhibitor: a Rational Treatment Approach

1 reference

12 December 2020

Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines

1 reference

12 December 2020

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

1 reference

12 December 2020

Effects of novel 5-HT1A receptor antagonists on measures of post-synaptic 5-HT1A receptor activation in vivo

1 reference

12 December 2020

Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin.

1 reference

12 December 2020

Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat.

1 reference

12 December 2020

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

12 December 2020

Anxiogenic stimuli in the elevated plus-maze.

1 reference

12 December 2020

Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors

1 reference

12 December 2020

Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems

1 reference

12 December 2020

Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus

1 reference

12 December 2020

The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test

1 reference

12 December 2020

Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

1 reference

12 December 2020

EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties

1 reference

12 December 2020

Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex.

1 reference

12 December 2020

The forced swimming test as a model for core and component behavioral effects of antidepressant drugs.

1 reference

12 December 2020

Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors

1 reference

12 December 2020

10.1111/J.1755-5949.2008.00067.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19499624%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference